Influenza and new crown cough treatment choose Lianhua Qingke Tablets

[ad_1]

Recently, Lianhua Qingke Tablets, an innovative traditional Chinese medicine in my country, has been included in the State Administration of Traditional Chinese Medicine’s “Guidelines for Home Medicine Intervention of Patients Infected with New Coronavirus” by the State Administration of Traditional Chinese Medicine because of its effectiveness and safety against the new coronavirus in basic, clinical research and practice. “, the World Federation of Chinese Medicine’s “Chinese Proprietary Medicine Prevention and Treatment Program for Children with New Coronavirus Infection” and the Chinese medicine diagnosis and treatment programs and home guidance recommendations of 19 provinces and cities. What advantages does it have, and what is the effect on cough and sputum caused by new crown infection?

　　Cough relief is obvious, a new choice for new crown drugs

Whether it is new coronary pneumonia or flu, one of the main symptoms is coughing. For the public, this is a well-known “hot knowledge”. And Lianhua Qingke Tablets, from the point of view of relieving cough, clears lung heat, eliminates phlegm and eliminates pathogenic factors, and maintains the health of the respiratory system.

It is understood that Lianhua Qingke Tablets is based on the treatment method of “dispelling lung heat, resolving phlegm and relieving cough”. Lung heat, Qingjin Huatan Decoction (Scutellaria baicalensis, Morus alba, Fritillaria, Chenpi) in Ming Dynasty Ye Wenling’s “Medical Tongzhi” combined with Pinellia, Peucedanum to clear lung heat, reduce phlegm and relieve cough, mountain silver flower, forsythia , Arctium clears heat and detoxifies, penetrates heat and expresses the surface, rhubarb clears the organs and vents the lungs. The prescription complies with the physiological characteristics of the lungs, and mainly focuses on clearing the lungs and dispelling pathogenic factors. It clears away lung-heat, relieves cough and resolves phlegm quickly, can significantly shorten the frequency of coughing and expectoration per unit time, relieves airway spasm, and has a significant antitussive effect. ; At the same time, by reducing sputum production, diluting sputum viscosity, and promoting sputum discharge, the respiratory tract is unobstructed.

In March 2022, the international academic journal “Evidence-Based Complementary and Alternative Medicine” published a scientific research titled “A Randomized Controlled Multi-center Clinical Study on the Efficacy and Safety of Lianhua Qingke Tablets in the Treatment of Mild and Common COVID-19” paper. The study showed that compared with the control group, the clinical symptom relief rate of Lianhuaqingke Tablets in the treatment of new coronary pneumonia can reach 98.61%, the median time for cough and sputum relief is shortened by 3 days, and the improvement rate of chest CT performance is increased by 14%. It can be seen that Lianhuaqingke Tablets can significantly improve the symptoms of cough and sputum in patients with new coronary pneumonia, improve respiratory function, and reduce lung damage.

At the same time, relevant basic pharmacological studies have confirmed that Lianhuaqingke Tablets can inhibit the replication of the new coronavirus in vitro and in vivo, reduce lung tissue inflammation, improve lung interstitial tissue hyperplasia, inhibit weight loss after infection, and regulate systemic immunity. Features.

　　Cough and phlegm, multiple advantages work together

Cough and phlegm are the most common symptoms of respiratory diseases. While inhibiting the reproduction of viruses and killing and inhibiting bacteria, it is also necessary to treat phlegm and cough. If the sputum wrapped in viruses and bacteria is not discharged in time, it will take to have more serious effects.

In this regard, Lianhuaqingke Tablets are also effective, and have multiple advantages such as relieving cough, reducing phlegm, and clearing lung. According to experimental data, compared with the control treatment group, the clinical symptom relief rate of the Lianhuaqingke Tablets group was 98.61%: 84.72%; the clinical symptom relief time was 4 days: 7 days; the cough relief rate was 98.44%: 84.51%; The cough relief rate was 100%: 82.35%. Compared with the control group, the fever reduction time of the Lianhuaqingke Tablets group was 2 days: 3 days, the cough relief time was 4 days: 7 days, and the cough relief time was 3 days: 6 Days, the improvement rate of chest CT was 86.11%:72.22%, and there were no adverse events.

In addition to the significant effect on improving influenza and new coronary pneumonia, Lianhuaqing cough tablets also have obvious effects on cough symptoms caused by other diseases. According to “A Randomized Double-Blind, Placebo-Controlled, Multicenter Clinical Study of Lianhuaqingke Tablets in the Treatment of Acute Tracheo-Bronchitis”, the cough disappearance rate of the patients in the Lianhuaqingke Tablets group was increased by 40.6% (49% : 8.4%).

A series of experimental studies have constituted a relatively complete chain of evidence for Lianhuaqingke Tablets in the treatment of cough and sputum from the perspectives of theory, practice, and evidence-based. Therefore, the drug has been included in the treatment plan for new coronary pneumonia by various provinces (cities) many times. And for the treatment of respiratory infectious diseases such as influenza.

Spring is the season when various respiratory viruses are raging. Recently, the temperature has fluctuated widely across the country, and the high incidence of influenza is superimposed with the new crown epidemic. Everyone’s respiratory tract is facing a severe test. In this regard, we should do more comprehensive protection and be responsible for our own health.

[ad_2]

Source link